Drug development is an arduous and expensive exercise. We seek to produce innovative compounds efficiently and effectively.

SEC Filings

Filing	Description	Date Filed	Size
10-Q	quarterly report	May 12, 1997	82.8 KB
SC 13G	statement of beneficial ownership	Apr 21, 1997	58.3 KB
DEF 14A	definitive proxy statement	Apr 3, 1997	158.2 KB
10-K405	annual report	Mar 28, 1997	343.3 KB
PRE 14A	preliminary proxy statement	Mar 21, 1997	158.2 KB
424B1	prospectus filed pursuant to rule 424	Mar 7, 1997	251.1 KB
S-3MEF	registration statement	Mar 6, 1997	61.4 KB
S-3/A	registration statement	Mar 4, 1997	271.5 KB
8-K	current report	Feb 25, 1997	110.5 KB
S-3	registration statement	Feb 25, 1997	387.8 KB
SC 13G/A	amended statement of beneficial ownership	Jan 24, 1997	52.8 KB
10-Q	quarterly report	Nov 13, 1996	83.5 KB
S-8	registration statement	Sep 19, 1996	60.7 KB
10-C	other	Aug 16, 1996	49.9 KB
10-Q	quarterly report	Aug 14, 1996	85.2 KB
424B1	prospectus filed pursuant to rule 424	Aug 9, 1996	246.4 KB
10-Q/A	amended quarterly report	Jul 23, 1996	169.3 KB
S-3/A	registration statement	Jul 12, 1996	261.7 KB
S-3	registration statement	Jul 3, 1996	354.0 KB
10-Q/A	amended quarterly report	May 21, 1996	144.9 KB
Showing 1,101-1,120 of 1123 Page: 1 ... 54 55 56 57  Previous 20 | Next 20